A
Anika Therapeutics, Inc.
ANIK · NASDAQ · Healthcare · 288M
Closing price
$19.58
+1.82% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.0×
Enterprise value / EBITDAEV/EBITDA
-69.7×
Free cash flow yieldFCF yield
1.6%
Return on equityROE
-7.6%
Operating margin
-9.8%
Net debt / EBITDAbalance-sheet strength
8.7×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.